Pramara Promotions IPO vs Saroja Pharma IPO

Comparison between Pramara Promotions IPO and Saroja Pharma IPO.

IPO Details

Pramara Promotions IPO is a SME Fixed Price IPO proposed to list at NSE SME while Saroja Pharma IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Pramara Promotions IPO is up to ₹14.49 Cr whereas the issue size of the Saroja Pharma IPO is up to ₹8.66 Cr. The final issue price of Pramara Promotions IPO is ₹63.00 per share and of Saroja Pharma IPO is ₹84.00 per share.

 Pramara Promotions IPOSaroja Pharma IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹63.00 per share₹84.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size2000 shares1600 shares
Fresh Issue Size23,00,000 shares10,30,400 shares
Fresh Issue Size (Amount)up to ₹14.49 Crup to ₹8.66 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total23,00,000 shares10,30,400 shares
Issue Size Total (Amount)up to ₹14.49 Crup to ₹8.66 Cr

IPO Timetable

Pramara Promotions IPO opens on Sep 01, 2023, while Saroja Pharma IPO opens on Aug 31, 2023. The closing date of Pramara Promotions IPO and Saroja Pharma IPO is Sep 05, 2023, and Sep 05, 2023, respectively.

 Pramara Promotions IPOSaroja Pharma IPO
Issue OpenSep 01, 2023Aug 31, 2023
Issue CloseSep 05, 2023Sep 05, 2023
Basis Of Allotment (Tentative)Sep 08, 2023Sep 08, 2023
Initiation of Refunds (Tentative)Sep 11, 2023Sep 11, 2023
Credit of Share (Tentative)Sep 12, 2023Sep 12, 2023
Listing date (Tentative)Sep 13, 2023Sep 13, 2023

Financials & KPIs

Pramara Promotions IPO P/E ratio is , as compared to Saroja Pharma IPO P/E ratio of 23.25.

 Pramara Promotions IPOSaroja Pharma IPO
Financials

Company Financials (Restated Consolidated)

Period Ended31 Mar 202331 Mar 202231 Mar 2021
Assets61.3961.9549.23
Total Income51.1949.4340.96
Profit After Tax2.231.350.33
NET Worth15.9713.7412.35
Reserves and Surplus9.4412.5411.15
Total Borrowing33.3131.3430.33
Amount in ₹ Crore

Company Financials (Restated Standalone)

Period Ended31 Mar 202331 Mar 202231 Mar 2021
Assets21.3415.518.22
Total Income50.3555.9636.75
Profit After Tax1.061.140.73
NET Worth5.094.030.94
Reserves and Surplus2.153.800.93
Total Borrowing10.196.143.02
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)95.41%100%
Promoter Shareholding (Post-Issue)69.81%73.02%
P/E Ratio23.25
Market Cap₹56.92 Cr.₹33.77 Cr.
ROE13.8715
ROCE15.2025
Debt/Equity2.072.00
EPS₹3.37₹3.61
RoNW13.8720.85

Shares Offered

In the Pramara Promotions IPO Retail Individual Investors (RII) are offered 11,50,000 shares while in Saroja Pharma IPO retail investors are offered 11,50,000 shares. Qualified Institutional Buyers (QIB) are offered in Pramara Promotions IPO and in Saroja Pharma IPO.

 Pramara Promotions IPOSaroja Pharma IPO
Market Maker Reservation1,24,000 shares54,400 shares
NII11,50,000 shares5,15,200 shares
RII11,50,000 shares5,15,200 shares
Total23,00,000 shares10,30,400 shares

Bids Received (Subscription)

Pramara Promotions IPO subscribed 25.56x in total, whereas Saroja Pharma IPO subscribed 8.86x.

 Pramara Promotions IPOSaroja Pharma IPO
NII (times)33.99x2.90x
RII (times)17.14x14.83x
Total (times)25.56x8.86x

Compare with others

Compare:

Pramara Promotions IPO Vs Saroja Pharma IPO